Metabolic disorders Archives

News and Trends 12 Dec 2024

Top biotech deals of November 2024

November has seen a variety of biotech deals take place to advance therapies across different stages in development.

December 12, 2024 - 9 minutesmins - By Roohi Mariam Peter

In Depth 20 Nov 2024

Hypoparathyroidism: rare endocrine disorder garners attention from biopharma in 2024

The hypoparathyroidism treatment space has made quite a buzz this year with a major drug approval, acquisition, and significant advances in clinical trials.

November 20, 2024 - 8 minutesmins - By Roohi Mariam Peter

Best in Biotech 29 Oct 2024

GPCR therapies: Eight promising biotechs hacking the cell signaling pathway

In this article, we take a look at eight biotechs that have acquired funding in recent years to fortify their GPCR-focused pipelines.

October 29, 2024 - 11 minutesmins - By Roohi Mariam Peter

News and Trends 10 Sep 2024

Long non-coding RNAs: what’s behind the growing “dark genome” buzz?

Recent deals have zoned in on drugs that target long non-coding RNAs and major moves are currently being made on the R&D front.

September 10, 2024 - 5 minutesmins - By Roohi Mariam Peter

Best in Biotech 5 Sep 2024

Six biotech companies that could revolutionize obesity treatments

In this article, we take a look at six biotechs focused on bringing drugs to treat obesity to the market.

September 5, 2024 - 9 minutesmins - By Roohi Mariam Peter

In Depth 27 Jun 2024

The 2024 drug approval list: Eight new treatments you should know about

In this article, we take a look at eight much-anticipated drugs that have been approved by regulators so far this year.

June 27, 2024 - 9 minutesmins - By Roohi Mariam Peter

In Depth 19 Jun 2024

MASH candidates make a splash after first drug approval

The first drug to treat MASH, a potentially life-threatening liver disease, was approved this year. More recent advancements bring hope to patients.

June 19, 2024 - 9 minutesmins - By Roohi Mariam Peter

Best in Biotech 14 Dec 2023

Seven companies shaping the future of precision medicine

Explore the forefront of healthcare innovation with these seven cutting-edge biopharma companies specializing in precision medicine.

December 14, 2023 - 9 minutesmins - By Roohi Mariam Peter

8 life science innovators you must meet at BioTrinity 2023

April 20, 2023 - 4 minutesmins - By External Contributor

News and Trends 24 Feb 2023

Resalis Therapeutics receives €10M to develop obesity and NAFLD treatment

Resalis Therapeutics has completed a seed financing round of €10 million to establish a non-coding RNA (ncRNA)-based therapeutic approach for the treatment of metabolic diseases. The funding will support the finalization of IND-enabling studies for the Resalis Therapeutics’ lead program, RES-010, which Resalis will initially develop as a novel treatment for obesity and nonalcoholic fatty […]

February 24, 2023 - 2 minutesmins - By Jim Cornall

News and Trends 16 Dec 2022

Sosei Heptares and Lilly enter agreement on diabetes and metabolic diseases

Sosei Group Corporation has entered a drug discovery collaboration with Eli Lilly and Company to discover, develop and commercialize small molecules that modulate novel G protein-coupled receptor (GPCR) targets associated with diabetes and metabolic diseases. The agreement will leverage Sosei Heptares’ StaR technology and structure-based drug design (SBDD) platform and Lilly’s drug development and commercialization […]

December 16, 2022 - 2 minutesmins - By Jim Cornall

beta-thalassemia blood APS antiphospholipid syndrome

News and Trends 11 Aug 2022

Study of drug to treat porphyria disorders initiated by Disc Medicine

A phase 2 clinical study of bitopertin in patients with erythropoietic protoporphyria (EPP) or X-linked protoporphyria (XLP) has been initiated by Disc Medicine. The announcement of the study, called BEACON, was made August 10. EPP or XLP belong to a group of the porphyria disorders, which are all characterized by abnormally high levels of chemicals, […]

August 11, 2022 - 3 minutesmins - By Liza Laws

Resources

Categories

10 biotech companies to watch in 2025

Biotech in 2024: A retrospective

Approaches

Therapeutic areas

Grab your free report on 3D organoids and explore their future potential

Five biosimilar companies you should know about

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

10 biotech companies to watch in 2025

Biotech in 2024: A retrospective

Grab your free report on 3D organoids and explore their future potential

Five biosimilar companies you should know about

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Metabolic disorders

Top biotech deals of November 2024

Hypoparathyroidism: rare endocrine disorder garners attention from biopharma in 2024

GPCR therapies: Eight promising biotechs hacking the cell signaling pathway

Long non-coding RNAs: what’s behind the growing “dark genome” buzz?

Six biotech companies that could revolutionize obesity treatments

The 2024 drug approval list: Eight new treatments you should know about

MASH candidates make a splash after first drug approval

Seven companies shaping the future of precision medicine

8 life science innovators you must meet at BioTrinity 2023

Resalis Therapeutics receives €10M to develop obesity and NAFLD treatment

Sosei Heptares and Lilly enter agreement on diabetes and metabolic diseases

Study of drug to treat porphyria disorders initiated by Disc Medicine

Subscribe to our newsletter to get the latest biotech news!

10 biotech companies to watch in 2025

Biotech in 2024: A retrospective

Grab your free report on 3D organoids and explore their future potential

Five biosimilar companies you should know about

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

10 biotech companies to watch in 2025

Biotech in 2024: A retrospective

Grab your free report on 3D organoids and explore their future potential

Five biosimilar companies you should know about

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!